+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Genetic Testing Market Analysis 2019

  • ID: 4769374
  • Report
  • Region: Global
  • 109 pages
  • Syngene Research
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories Inc.
  • Blueprint Genetic
  • Genomictre Inc
  • Molecular Inc.
  • Oxford Biodynamics Ltd
  • Roche Holding AG
  • MORE
The Global Genetic Testing market is expected to reach $ 69, 999.98 million by 2026 growing at a CAGR of 8.0% during 2018 to 2026. A genetic test is used to determine the DNA sequence of a certain region of the human genome. This region might be a whole gene or a share of a gene, or other areas thought to regulate genes. The test will look for certain changes in the sequence that is known to have consequences on the function of a gene.Factors such as increasing demand from patients for personalized medicines are driving the market growth. Though, high costs are restraining the market. Moreover, conjugation with other genomic technologies and increasing the growth of the pharmaceutical industry provide ample opportunities for market growth.

By Application, Cancer diagnosis segment acquired significant growth in the market. The increasing frequency of various types of cancer such as prostate cancer, breast cancer and lung cancer coupled with growing awareness pertaining to an early finding of cancer will stimulate the market growth.

The key vendors mentioned areThermo Fisher Scientific, Roche Holding AG, Qiagen N.V, Abbott Laboratories Inc., Oxford Biodynamics Ltd, Bio-Rad Laboratories, Myriad Genetics Inc., Molecular Inc., Luminex Corporation, HTG Molecular Diagnostics Inc, GenomictreInc, F. Hoffmann-La Roche Ltd, Eurofins Scientific SE (Eurofins), Danaher Corporation (Cepheid) and Blueprint Genetic.

Test Types Covered:
  • Carrier testing
  • Forensic Testing
  • Gas Chromatography/ Mass Spectrometry
  • High-performance liquid chromatography
  • Molecular Genetic Test/ DNA Test
  • Nutrigenomic Testing
  • Pharmacogenomic testing
  • Predictive and Presymptomatic Testing
  • Prenatal and Newborn Testing
  • Tandem Mass Spectrometry
  • Other Test Types
Diseases Covered:
  • Thalassemia
  • Sickle Cell Anemia
  • Rare Diseases
  • Huntington’s Disease
  • Duchenne Muscular Dystrophy
  • Cystic Fibrosis
  • Cancer
  • Alzheimer’s Disease
  • Other Diseases
Testing Samples Covered:
  • Tumors
  • Saliva
  • Hair
  • Blood
  • Other Testing Samples
Technologies Covered:
  • Biochemical Testing
  • Molecular Testing
  • Cytogenetic Testing
Applications Covered:
  • Prescribed Genetic Testing
  • Predisposition Cancer Genetic Testing
  • Pharmacogenomics Genetic Testing
  • Neurogenetic Disorder Testing
  • Muscular Dystrophies
  • Genetic diseases diagnosis
  • Direct to consumer (DTC) Genetic Testing
  • Cardiovascular diseases diagnosis
  • Cancer diagnosis
  • Other Applications
End Users Covered:
  • Nursing Homes
  • Hospitals
  • Clinical Diagnostics Laboratories
  • Blood Bank
  • Biopharmaceuticals Companies and Research Centres
  • Other End Users
Regions Covered:
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa
Key Questions Answered in this Report:
  • How this market evolved since the year 2016
  • Market size estimations, forecasts and CAGR for all the segments presented in the scope
  • Key Market Developments and financials of the key players
  • Opportunity Analysis for the new entrants
  • SWOT Analysis of the key players
  • Fastest growing markets analyzed during the forecast period
*Please Note: This report will be delivered within 48 hours of ordering.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories Inc.
  • Blueprint Genetic
  • Genomictre Inc
  • Molecular Inc.
  • Oxford Biodynamics Ltd
  • Roche Holding AG
  • MORE
1 Market Synopsis

2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources

3 Market Dynamics
3.1 Drivers
3.2 Restraints

4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Genetic Testing Market, By Test Type
5.1 Introduction
5.2 Carrier testing
5.3 Forensic Testing
5.4 Gas Chromatography/ Mass Spectrometry
5.5 High-performance liquid chromatography
5.6 Molecular Genetic Test/ DNA Test
5.7 Nutrigenomic Testing
5.8 Pharmacogenomic testing
5.9 Predictive and Presymptomatic Testing
5.10 Prenatal and Newborn Testing
5.11 Tandem Mass Spectrometry
5.12 Other Test Types

6 Global Genetic Testing Market, By Disease
6.1 Introduction
6.2 Thalassemia
6.3 Sickle Cell Anemia
6.4 Rare Diseases
6.5 Huntington’s Disease
6.6 Duchenne Muscular Dystrophy
6.7 Cystic Fibrosis
6.8 Cancer
6.9 Alzheimer’s Disease
6.10 Other Diseases

8 Global Genetic Testing Market, By Testing Sample
8.1 Introduction
8.2 Tumors
8.3 Saliva
8.4 Hair
8.5 Blood
8.6 Other Testing Samples

9 Global Genetic Testing Market, By Technology
9.1 Introduction
9.2 Biochemical Testing
9.3 Molecular Testing
9.4 Cytogenetic Testing

10 Global Genetic Testing Market, By Application
10.1 Introduction
10.2 Prescribed Genetic Testing
10.3 Predisposition Cancer Genetic Testing
10.4 Pharmacogenomics Genetic Testing
10.5 Neurogenetic Disorder Testing
10.6 Muscular Dystrophies
10.7 Genetic diseases diagnosis
10.8 Direct to consumer (DTC) Genetic Testing
10.9 Cardiovascular diseases diagnosis
10.10 Cancer diagnosis
10.11 Other Applications

11 Global Genetic Testing Market, By End User
11.1 Introduction
11.2 Nursing Homes
11.3 Hospitals
11.4 Clinical Diagnostics Laboratories
11.5 Blood Bank
11.6 Biopharmaceuticals Companies and Research Centers
11.7 Other End Users

12 Global Genetic Testing Market, By Geography
12.1 Introduction
12.2 North America
12.3 Europe
12.4 Asia Pacific
12.5 South America
12.6 Middle East & Africa

13 Strategic Benchmarking

14 Vendors Landscape
14.1 Thermo Fisher Scientific
14.2 Roche Holding AG
14.3 Qiagen N.V
14.4 Abbott Laboratories Inc.
14.5 Oxford Biodynamics Ltd
14.6 Bio-Rad Laboratories
14.7 Myriad Genetics Inc.
14.8 Molecular Inc.
14.9 Luminex Corporation
14.10 HTG Molecular Diagnostics Inc
14.11 Genomictre Inc
14.12 F. Hoffmann-La Roche Ltd
14.13 Eurofins Scientific SE (Eurofins)
14.14 Danaher Corporation (Cepheid)
14.15 Blueprint Genetic

List of Data Tables
Table 1 Global Genetic Testing Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Genetic Testing Market Outlook, By Test Type (2016-2026) ($MN)
Table 3 Global Genetic Testing Market Outlook, By Carrier testing (2016-2026) ($MN)
Table 4 Global Genetic Testing Market Outlook, By Forensic Testing (2016-2026) ($MN)
Table 5 Global Genetic Testing Market Outlook, By Gas Chromatography/ Mass Spectrometry (2016-2026) ($MN)
Table 6 Global Genetic Testing Market Outlook, By High-performance liquid chromatography (2016-2026) ($MN)
Table 7 Global Genetic Testing Market Outlook, By Molecular Genetic Test/ DNA Test (2016-2026) ($MN)
Table 8 Global Genetic Testing Market Outlook, By Nutrigenomic Testing (2016-2026) ($MN)
Table 9 Global Genetic Testing Market Outlook, By Pharmacogenomic testing (2016-2026) ($MN)
Table 10 Global Genetic Testing Market Outlook, By Predictive and Presymptomatic Testing (2016-2026) ($MN)
Table 11 Global Genetic Testing Market Outlook, By Prenatal and Newborn Testing (2016-2026) ($MN)
Table 12 Global Genetic Testing Market Outlook, By Tandem Mass Spectrometry (2016-2026) ($MN)
Table 13 Global Genetic Testing Market Outlook, By Other Test Types (2016-2026) ($MN)
Table 14 Global Genetic Testing Market Outlook, By Disease (2016-2026) ($MN)
Table 15 Global Genetic Testing Market Outlook, By Thalassemia (2016-2026) ($MN)
Table 16 Global Genetic Testing Market Outlook, By Sickle Cell Anemia (2016-2026) ($MN)
Table 17 Global Genetic Testing Market Outlook, By Rare Diseases (2016-2026) ($MN)
Table 18 Global Genetic Testing Market Outlook, By Huntington’s Disease (2016-2026) ($MN)
Table 19 Global Genetic Testing Market Outlook, By Duchenne Muscular Dystrophy (2016-2026) ($MN)
Table 20 Global Genetic Testing Market Outlook, By Cystic Fibrosis (2016-2026) ($MN)
Table 21 Global Genetic Testing Market Outlook, By Cancer (2016-2026) ($MN)
Table 22 Global Genetic Testing Market Outlook, By Alzheimer’s Disease (2016-2026) ($MN)
Table 23 Global Genetic Testing Market Outlook, By Other Diseases (2016-2026) ($MN)
Table 24 Global Genetic Testing Market Outlook, By Testing Sample (2016-2026) ($MN)
Table 25 Global Genetic Testing Market Outlook, By Tumors (2016-2026) ($MN)
Table 26 Global Genetic Testing Market Outlook, By Saliva (2016-2026) ($MN)
Table 27 Global Genetic Testing Market Outlook, By Hair (2016-2026) ($MN)
Table 28 Global Genetic Testing Market Outlook, By Blood (2016-2026) ($MN)
Table 29 Global Genetic Testing Market Outlook, By Other Testing Samples (2016-2026) ($MN)
Table 30 Global Genetic Testing Market Outlook, By Technology (2016-2026) ($MN)
Table 31 Global Genetic Testing Market Outlook, By Biochemical Testing (2016-2026) ($MN)
Table 32 Global Genetic Testing Market Outlook, By Molecular Testing (2016-2026) ($MN)
Table 33 Global Genetic Testing Market Outlook, By Cytogenetic Testing (2016-2026) ($MN)
Table 34 Global Genetic Testing Market Outlook, By Application (2016-2026) ($MN)
Table 35 Global Genetic Testing Market Outlook, By Prescribed Genetic Testing (2016-2026) ($MN)
Table 36 Global Genetic Testing Market Outlook, By Predisposition Cancer Genetic Testing (2016-2026) ($MN)
Table 37 Global Genetic Testing Market Outlook, By Pharmacogenomics Genetic Testing (2016-2026) ($MN)
Table 38 Global Genetic Testing Market Outlook, By Neurogenetic Disorder Testing (2016-2026) ($MN)
Table 39 Global Genetic Testing Market Outlook, By Muscular Dystrophies (2016-2026) ($MN)
Table 40 Global Genetic Testing Market Outlook, By Genetic diseases diagnosis (2016-2026) ($MN)
Table 41 Global Genetic Testing Market Outlook, By Direct to consumer (DTC) Genetic Testing (2016-2026) ($MN)
Table 42 Global Genetic Testing Market Outlook, By Cardiovascular diseases diagnosis (2016-2026) ($MN)
Table 43 Global Genetic Testing Market Outlook, By Cancer diagnosis (2016-2026) ($MN)
Table 44 Global Genetic Testing Market Outlook, By Other Applications (2016-2026) ($MN)
Table 45 Global Genetic Testing Market Outlook, By End User (2016-2026) ($MN)
Table 46 Global Genetic Testing Market Outlook, By Nursing Homes (2016-2026) ($MN)
Table 47 Global Genetic Testing Market Outlook, By Hospitals (2016-2026) ($MN)
Table 48 Global Genetic Testing Market Outlook, By Clinical Diagnostics Laboratories (2016-2026) ($MN)
Table 49 Global Genetic Testing Market Outlook, By Blood Bank (2016-2026) ($MN)
Table 50 Global Genetic Testing Market Outlook, By Biopharmaceuticals Companies and Research Centers (2016-2026) ($MN)
Table 51 Global Genetic Testing Market Outlook, By Other End Users (2016-2026) ($MN)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Thermo Fisher Sceintific
  • Roche Holding AG
  • Qiagen N.V
  • Abbott Laboratories Inc.
  • Oxford Biodynamics Ltd
  • Bio-Rad Laboratories
  • Myriad Genetics Inc.
  • Molecular Inc.
  • Luminex Corporation
  • HTG Molecular Diagnostics Inc
  • Genomictre Inc
  • F. Hoffmann-La Roche Ltd
  • Eurofins Scientific SE (Eurofins)
  • Danaher Corporation (Cepheid)
  • Blueprint Genetic
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4769374
Adroll
adroll